EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
1 clinical trials · Condition
◉ Watch EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
| Record | Firm | Date |
|---|---|---|
| Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies (NCT02822495) | Atara Biotherapeutics |
Track EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) automatically
Every clearance here is in the API, with alerts when new ones post.